Lawrence G. Hamel

2015

In 2015, Lawrence G. Hamel earned a total compensation of $488.9K as Chief Development Officer at AcelRx Pharmaceuticals, a 55% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$157,290
Salary$321,000
Other$10,600
Total$488,890

Hamel received $321K in salary, accounting for 66% of the total pay in 2015.

Hamel also received $157.3K in non-equity incentive plan and $10.6K in other compensation.

Rankings

In 2015, Lawrence G. Hamel's compensation ranked 10,919th out of 13,638 executives tracked by ExecPay. In other words, Hamel earned more than 19.9% of executives.

ClassificationRankingPercentile
All
10,919
out of 13,638
20th
Division
Manufacturing
4,170
out of 5,190
20th
Major group
Chemicals And Allied Products
1,530
out of 1,854
18th
Industry group
Drugs
1,261
out of 1,528
18th
Industry
Pharmaceutical Preparations
984
out of 1,182
17th
Source: SEC filing on April 28, 2017.

Hamel's colleagues

We found five more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2015.

2015

Howard Rosen

AcelRx Pharmaceuticals

Chief Executive Officer

2015

Timothy Morris

AcelRx Pharmaceuticals

Chief Financial Officer

2015

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2015

Richard King

AcelRx Pharmaceuticals

Chief Executive Officer

2015

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

News

You may also like